ABBOTINDIA.NS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 07:26):

Stats
Šios dienos apimtis	883.00
Vidutinė apimtis	17 078.00
Rinkos kapitalizacija	550.27B
EPS	INR0 ( 2024-01-31 )
Kita pelno data	( INR0 ) 2024-05-16
Last Dividend	INR145.00 ( 2023-07-20 )
Next Dividend	INR0 ( N/A )
P/E	48.08
ATR14	INR23.18 (0.09%)

Tūris Koreliacija

Ilgas: 0.17 (neutral)

Trumpas: -0.57 (weak negative)

Signal:(45.153) Neutral

Abbott India Limited Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
TANLA.NS	0.888
CSLFINANCE.NS	0.882
KARMAENG.NS	0.872
RAMRAT.NS	0.865
FACT.NS	0.858
ICICIPRULI.NS	0.858
JAYBARMARU.NS	0.855
JITFINFRA.NS	0.854
PATANJALI.NS	0.854
IVC.NS	0.849

10 Labiausiai neigiamai susiję koreliacijos
CONSUMBEES.NS	-0.92
NIF100BEES.NS	-0.908
DALALSTCOM.NS	-0.884
SRF.NS	-0.884
IEX.NS	-0.867
FLUOROCHEM.NS	-0.859
MPHASIS.NS	-0.858
ANURAS.NS	-0.851
NIITLTD.NS	-0.848
ICICITECH.NS	-0.846

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Abbott India Limited Koreliacija - Valiuta/Žaliavos

-0.49
( neutral )

-0.18
( neutral )

0.52
( weak )

-0.05
( neutral )

-0.16
( neutral )

-0.24
( neutral )

Abbott India Limited Finansinės ataskaitos

Annual	2022
Pajamos:	INR53.49B
Bruto pelnas:	INR23.74B (44.38 %)
EPS:	INR446.80

FY	2022
Pajamos:	INR53.49B
Bruto pelnas:	INR23.74B (44.38 %)
EPS:	INR446.80

FY	2022
Pajamos:	INR49.10B
Bruto pelnas:	INR22.53B (45.88 %)
EPS:	INR375.86

FY	2021
Pajamos:	INR43.08B
Bruto pelnas:	INR19.17B (44.50 %)
EPS:	INR325.04

Financial Reports:

No articles found.

Abbott India Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR130.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR145.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Abbott India Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 4.43 - low (47.16%) | Divividend Growth Potential Score: 6.44 - Stable (28.83%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR17.50	2008-03-28
Last Dividend	INR145.00	2023-07-20
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	16	--
Total Paid Out	INR821.50	--
Avg. Dividend % Per Year	0.52%	--
Score	2.5	--
Div. Sustainability Score	4.43
Div.Growth Potential Score	6.44
Div. Directional Score	5.44	--

Next Divdend (Est)
(2024-07-17)

INR158.84 Estimate 3.11 %

Dividend Stability

0.25 Very Poor

Dividend Score

2.50

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR5.00	0.08%
2019	INR15.00	0.20%
2020	INR143.00	1.09%
2021	INR155.00	0.98%
2022	INR130.00	0.67%
2023	INR145.00	0.68%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TFCILTD.NS	Dividend Junior	2023-08-11	Annually	23	1.38%
ORIENTBELL.NS	No Dividend Player	2023-07-18	Annually	18	0.14%
IRCON.NS	Dividend Knight	2023-09-05	Semi-Annually	6	3.39%
CROMPTON.NS	Dividend Junior	2023-07-06	Annually	8	0.52%
SHIVALIK.NS	Dividend Junior	2023-09-22	Annually	3	0.03%
MANORAMA.NS	Dividend Junior	2023-09-11	Insufficient data to determine frequency	2	0.07%
GRAVITA.NS	Dividend Junior	2023-09-04	Annually	14	0.72%
BAJAJHLDNG.NS	Dividend Junior	2023-09-29	Annually	22	1.20%
UBL.NS	Dividend Junior	2023-08-03	Annually	17	0.27%
POLYCAB.NS	Dividend Knight	2023-06-21	Annually	6	0.50%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.199	1.500	6.01	9.02	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.364	1.500	7.07	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	113.56	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	360.54	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	344.67	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.448	1.000	5.87	5.87	[0.2 - 0.8]
operatingProfitMarginTTM	0.270	1.000	6.61	6.61	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.43

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	48.03	1.000	5.25	0	[1 - 100]
returnOnEquityTTM	0.364	2.50	8.12	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	344.67	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.560	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	360.54	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	3.92	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.133	1.000	9.17	0	[0.1 - 0.5]
Total Score				6.44

Abbott India Limited

Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, pain management, pre-term labor, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was incorporated in 1944 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.